Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▴	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
COGT	Cogent Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$328.94M	n/a	-51.7%	n/a	-$2.16
CNTB	Connect Biopharma Holdings Ltd Manufacturing · Year ended 2025-12-31 · USD	$64.0K	-$55.48M	n/m	-132.2%	-99.8%	-$1.00
CNTX	Context Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$36.12M	n/a	-59.7%	n/a	-$0.38
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
CRMD	CorMedix Inc. Manufacturing · Year ended 2025-12-31 · USD	$311.71M	$163.06M	52.3%	40.2%	617.0%	$2.04
CRBP	Corbus Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$78.54M	n/a	-53.2%	n/a	-$5.90
CRVS	Corvus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.28M	n/a	-25.0%	n/a	-$0.53
COYA	Coya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.95M	-$21.23M	-267.1%	-49.3%	123.6%	-$1.27
CYRX	Cryoport, Inc. Manufacturing · Year ended 2025-12-31 · USD	$176.18M	$78.30M	44.4%	15.6%	12.4%	$1.40
CUE	Cue Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$27.47M	-$26.60M	-96.9%	-100.6%	195.7%	-$0.28
CURX	Curanex Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$4.23M	n/a	-37.7%	n/a	-$0.17
CYDY	CytoDyn Inc. Manufacturing · Year ended 2026-05-31 · USD	n/a	-$42.70M	n/a	n/a	n/a	-$0.03
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
DMRA	Damora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$209.84M	n/a	-87.3%	n/a	$3.98
DARE	Dare Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.03M	-$13.40M	n/m	-471.4%	n/m	-$1.20
DCOY	Decoy Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.52M	n/a	-212.6%	n/a	-$129.10
DRMA	Dermata Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.56M	n/a	-121.5%	n/a	-$8.16
DSGN	Design Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$69.79M	n/a	-32.8%	n/a	-$1.22
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
IRON	Disc Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$212.18M	n/a	-28.7%	n/a	-$6.01
DWTX	Dogwood Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.26M	n/a	-45.7%	n/a	-$7.13
DYN	Dyne Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$446.21M	n/a	-45.9%	n/a	-$3.47
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
ELTP	Elite Pharmaceuticals Inc Manufacturing · Year ended 2026-03-31 · USD	$148.87M	$44.87M	30.1%	45.4%	77.1%	$0.03

Rows per page: 2550 100